ACET: Adicet Bio, Inc. Stock

by  •  • Comments Off on ACET: Adicet Bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 58.88
Enterprise Value ($M) 30.75
Book Value ($M) 161.45
Book Value / Share 1.95
Price / Book 0.36
NCAV ($M) 123.74
NCAV / Share 1.50
Price / NCAV 0.48

Profitability (mra)
Return on Invested Capital (ROIC) -0.66
Return on Assets (ROA) -0.40
Return on Equity (ROE) -0.45

Liquidity (mrq)
Quick Ratio 9.34
Current Ratio 9.34

Balance Sheet (mrq) ($M)
Current Assets 153.56
Assets 191.27
Liabilities 29.82
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -127.61
Net Income -117.12
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -92.38
Cash from Investing -119.24
Cash from Financing 111.31

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-15 13G/A Tang Capital Management Llc 9.90 0.08
11-14 13G/A Rtw Investments, Lp 0.00 -100.00
11-14 13G/A Commodore Capital Lp 0.00 -100.00
11-14 13G/A Ra Capital Management, L.p. 9.99 7.95
11-13 13G/A Cowen Financial Products LLC 0.00 -100.00
10-08 13G/A Millennium Management Llc 2.40 -50.36
07-10 13G/A Morgan Stanley 1.40 -60.08

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 47,351 192,476 24.60
2025-05-29 132,415 465,336 28.46
2025-05-28 97,285 1,022,667 9.51
2025-05-27 221,592 478,097 46.35

(click for more detail)

Similar Companies
ACIU – AC Immune SA ACRV – Acrivon Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io